Skip to main content
JA Clinical Reports

Table 2 Incidence of AKI in each group

From: Amino acids to prevent cardiac surgery-associated acute kidney injury: a randomized controlled trial

 

Control group

Intervention group

Effect

P value

 

n = 32

n = 33

  

AKI

56.2 (18)

30.3 (10)

HR 0.44 (0.20–0.95)

0.04

Cre-AKI

43.8 (14)

27.3 (9)

HR 0.53 (0.23–1.24)

0.14

Cre-AKI stage

 0

56.2 (18)

72.7 (24)

OR 0.39 (0.13–1.17)

0.09

 1

31.2 (10)

24.2 (8)

  

 2

3.1 (1)

3.0 (1)

  

 3

9.4 (3)

0.0 (0)

  
  1. Proportions (%) and frequencies are presented for each variable. For the full analysis set, Cox proportional hazards regression analysis was performed for AKI and Cre-AKI, and ordered logistic regression analysis was performed for Cre-AKI stage. Numbers in parentheses in the Effect column indicate 95% confidence intervals
  2. AKI acute kidney injury, Cre-AKI acute kidney injury defined only on the basis of the creatinine value, in accordance with the Kidney Disease Improving Global Outcomes Criteria, Cre-AKI stage, staged Cre-AKI, HR hazard ratio, OR odds ratio
Back to article page